Mesoblast Ltd. (MESO)
Mesoblast Market Cap : 1.509B for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2026 | 1.509B |
| November 17, 2026 | 1.544B |
| November 16, 2026 | 1.614B |
| November 13, 2026 | 1.721B |
| November 12, 2026 | 1.699B |
| November 11, 2026 | 1.770B |
| November 10, 2026 | 1.814B |
| November 09, 2026 | 1.872B |
| November 06, 2026 | 1.850B |
| November 05, 2026 | 1.828B |
| November 04, 2026 | 1.853B |
| November 03, 2026 | 1.915B |
| November 02, 2026 | 1.885B |
| October 30, 2026 | 1.966B |
| October 29, 2026 | 2.032B |
| October 28, 2026 | 1.736B |
| October 27, 2026 | 1.709B |
| October 26, 2026 | 1.607B |
| October 23, 2026 | 1.592B |
| October 22, 2026 | 1.627B |
| October 21, 2026 | 1.664B |
| October 20, 2026 | 1.609B |
| October 19, 2026 | 1.550B |
| October 16, 2026 | 1.722B |
| October 15, 2026 | 1.809B |
| Date | Value |
|---|---|
| October 14, 2026 | 1.788B |
| October 13, 2026 | 1.802B |
| October 12, 2026 | 1.850B |
| October 09, 2026 | 1.853B |
| October 08, 2026 | 1.783B |
| October 07, 2026 | 1.808B |
| October 06, 2026 | 1.765B |
| October 05, 2026 | 1.844B |
| October 02, 2026 | 1.826B |
| October 01, 2026 | 1.857B |
| September 30, 2026 | 1.900B |
| September 29, 2026 | 1.928B |
| September 28, 2026 | 1.880B |
| September 25, 2026 | 1.961B |
| September 24, 2026 | 2.007B |
| September 23, 2026 | 1.983B |
| September 22, 2026 | 2.064B |
| September 21, 2026 | 2.007B |
| September 18, 2026 | 1.962B |
| September 17, 2026 | 1.928B |
| September 16, 2026 | 1.868B |
| September 15, 2026 | 1.911B |
| September 14, 2026 | 1.948B |
| September 11, 2026 | 2.007B |
| September 10, 2026 | 2.010B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Telix Pharmaceuticals Ltd. | 3.044B |
| Immutep Ltd. | 23.95M |
| CSL Ltd. | 63.02B |
| Ceryvyn Therapeutics Ltd. | 4.788M |
| Propanc Biopharma, Inc. | 1.731M |
Market Cap Related Metrics
| PS Ratio | 12.50 |
| Price to Book Value | 1.990 |
| Price | 11.64 |
| Earnings Yield | -3.83% |